Effects of Rubiadin isolated from Prismatomeris connata on anti‐hepatitis B virus activity in vitro

Citations Over TimeTop 25% of 2017 papers

Abstract

Prismatomeris connata was a kind of Rubiaceae plant for treatment of hepatitis, hepatic fibrosis and silicosis. Whereas, the effective components of Prismatomeris connata remains unexplored. The aim of this study was to investigate the inhibitory effects and mechanisms of Rubiadin isolated from Prismatomeris connata against HBV using HepG2.2.15 cells. The levels of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and hepatitis B core antigen (HBcAg) in the supernatants or cytoplasm were examined using by enzyme-linked immunosorbent assay. HBV DNA was qualified q-PCR. Rubiadin was isolated by silica gel column. The structure of the compound was elucidated by HPLC, FT-IR, 1 H-NMR, 13 C-NMR and identified as 1,3-Dihydroxy-2-methyl-9, 10-anthraquinone. Rubiadin significantly decreased HBeAg,HBcAg secretion level and inhibit HBV DNA replication. Rubiadin inhibits the proliferation of the cells and HBx protein expression in a dose-dependent manner. The intracellular calcium concentration was significantly reduced. These results demonstrated that Rubiadin could inhibit HepG2.2.15 cells proliferation, reduce the level of HBx expression, and intracellular free calcium, which might become a novel anti-HBV drug candidate.

Related Papers

• → Distribution of Hepatitis B Surface and Core Antigens in Human Liver Cell Carcinoma and Surrounding Nontumorous Liver<xref ref-type="fn" rid="fn2">2</xref>(1982)34 cited
• → Significance of Serum and Hepatic Markers of Hepatitis B Viral Infection in Hbsag–Positive and Hbsag–Negative Chronic Active Hepatitis(1985)15 cited
• The relationship between the expression of HBsAg and HBcAg in the liver tissue and the content of HBV-DNA in serum of patients with chronic hepatitis B(2007)
• Immunogenicity of recombinant hepatitis B core antigen and its immunopotentiation to hepatitis B surface antigen(2013)
• [Demonstration of intrahepatic HBsAg and HBcAg in chronic liver disease by double staining].(1991)